TLR3 has been implicated in mediating sterile pathologies in CVDs associated with immune responses, including pulmonary artery hypertension (PAH), atherosclerosis, myocardial infarction (MI), ischemia/reperfusion (I/R), and heart failure [30–32]. This evidence concerns the gene TLR3 and heart failure.